August 28, 2026
“…One notable example of Druckenmiller’s risk-taking is his investments in clinical-stage biotech stocks. In the first quarter of 2026, his Duquesne Family Office initiated a new stake in Revolution Medicines (NASDAQ: RVMD) worth $30.7 million at the end of Q1… Over the last… Continue Reading…
January 23, 2026
“…In the third quarter, Druckenmiller sold his position in semiconductor company Broadcom (NASDAQ: AVGO) and started a position in flash memory maker Sandisk (NASDAQ: SNDK), a stock that has added 1,050% since it was spun off from Western Digital in February 2025… Wall Street estimates Broadcom’s adjusted… Continue Reading…
Recent Comments